MEI Pharma, Inc. (MEIP)
NASDAQ: MEIP · IEX Real-Time Price · USD
2.860
-0.040 (-1.38%)
At close: May 31, 2024, 4:00 PM
2.920
+0.060 (2.10%)
After-hours: May 31, 2024, 4:43 PM EDT
MEI Pharma Market Cap
MEI Pharma has a market cap or net worth of $19.06 million as of May 31, 2024. Its market cap has decreased by -60.13% in one year.
Market Cap
19.06M
Enterprise Value
-25.83M
1-Year Change
-60.13%
Ranking
Category
Stock Price
$2.86
Market Cap Chart
Since December 31, 2003, MEI Pharma's market cap has decreased from $670.20M to $19.06M, a decrease of -97.16%. That is a compound annual growth rate of -15.99%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 31, 2024 | 19.10M | -1.04% |
May 30, 2024 | 19.30M | -1.03% |
May 29, 2024 | 19.50M | -4.41% |
May 28, 2024 | 20.40M | -1.45% |
May 24, 2024 | 20.70M | -0.96% |
May 23, 2024 | 20.90M | -1.88% |
May 22, 2024 | 21.30M | 2.40% |
May 21, 2024 | 20.80M | 0.48% |
May 20, 2024 | 20.70M | -1.43% |
May 17, 2024 | 21.00M | 7.69% |
May 16, 2024 | 19.50M | -5.80% |
May 15, 2024 | 20.70M | -1.90% |
May 14, 2024 | 21.10M | 1.44% |
May 13, 2024 | 20.80M | 3.48% |
May 10, 2024 | 20.10M | -1.95% |
May 9, 2024 | 20.50M | -2.84% |
May 8, 2024 | 21.10M | 0.96% |
May 7, 2024 | 20.90M | -1.88% |
May 6, 2024 | 21.30M | 4.41% |
May 3, 2024 | 20.40M | - |
May 2, 2024 | 20.40M | - |
May 1, 2024 | 20.40M | 0.49% |
Apr 30, 2024 | 20.30M | -0.98% |
Apr 29, 2024 | 20.50M | 0.99% |
Apr 26, 2024 | 20.30M | -1.93% |
View and export this data all the way back to 2003.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Jaguar Health | 20.63M |
iBio, Inc. | 20.52M |
Indaptus Therapeutics | 20.24M |
Lyra Therapeutics | 20.00M |
Evaxion Biotech | 19.14M |
Mainz Biomed B.V. | 19.02M |
Kala Pharmaceuticals | 18.93M |
NeuroSense Therapeutics | 18.80M |